From the Journals

Statins and Survival After 80

Cohort analysis associates primary prevention with lower mortality and coronary morbidity

Share

Statin therapy in adults aged 80 and older without prior cardiovascular disease was linked to improved survival rates and fewer coronary events, according to a retrospective cohort study using electronic health records. This study, involving 15,745 patients from Clalit Health Services in Israel, found that 20% of statin users died compared to 37% of nonusers over an average follow-up of 4 years. Although the evidence base is limited and lacks clear guidelines for this age group, findings suggest that ongoing statin treatment may confer significant health benefits in older adults.

Original Source(s)

Statins and Survival After 80

  • by Jess Allerton

  • March 19, 2026

Related Content

ECPR Shows Promise in Cardiac Arrest

Timing, patient selection, and system factors continue to shape its role

PREVENT Equations Show How Age, Risk Factors Shape CVD Risk

Systematic analysis demonstrates how kidney disease, diabetes, and other factors accelerate 10-year cardiovascular risk, helping guide clinician–patient prevention discussions.

Premature Menopause Tied to Higher Lifetime CHD Risk

Lifetime risk estimates evaluated by menopause timing.